ASA physical status classification system
ASA Physical Status Classification System[edit]
Introduction[edit]
The ASA Physical Status Classification System is a widely used framework for assessing the fitness of patients prior to surgery. Developed by the American Society of Anesthesiologists (ASA), this system categorizes patients based on their preoperative physical health.
Development and History[edit]
Initially adopted in 1963, the ASA system initially included five categories. A sixth category was added later to include brain-dead patients who are organ donors. This system helps in evaluating the risks associated with anesthesia and surgical procedures.
Classification Categories[edit]
The ASA classification is divided into six categories:
- ASA I: A healthy patient with no systemic disease.
- ASA II: A patient with mild systemic disease that does not limit activity.
- ASA III: A patient with severe systemic disease that limits activity but is not incapacitating.
- ASA IV: A patient with severe systemic disease that is a constant threat to life.
- ASA V: A moribund patient who is not expected to survive without the operation.
- ASA VI: A declared brain-dead patient whose organs are being removed for donor purposes.
Application in Clinical Practice[edit]
The ASA classification is used by anesthesiologists and surgical teams to:
- Assess and communicate the preoperative condition of a patient.
- Plan for the level of care and resources required for surgery.
- Estimate the risk of anesthesia-related complications.
Importance and Benefits[edit]
This system is crucial for:
- Ensuring patient safety and optimizing surgical outcomes.
- Guiding informed consent discussions with patients.
- Research and comparison of surgical and anesthesia-related outcomes.
Limitations and Challenges[edit]
Despite its widespread use, the ASA classification has limitations, including:
- Subjectivity in patient assessment.
- Variability in interpretation among clinicians.
- Limited ability to predict postoperative outcomes in isolation.
Updates and Modifications[edit]
Over time, there have been suggestions for modifications to improve its predictive value and reduce subjectivity.
See Also[edit]
References[edit]
External Links[edit]
- American Society of Anesthesiologists - ASA Physical Status Classification System
- National Center for Biotechnology Information - Preoperative Assessment
|
This article is a stub You can help WikiMD by registering and expanding it with useful details, internal links, formatting, and categories. Editing is available only to registered and verified users. WikiMD is a comprehensive, free health and wellness encyclopedia. |
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian